Rhythm Pharmaceuticals Inc (RYTM)
41.51
+1.71
(+4.30%)
USD |
NASDAQ |
May 01, 16:00
41.51
0.00 (0.00%)
After-Hours: 18:50
Rhythm Pharmaceuticals 1 Year Total Returns (Daily): 97.32% for April 30, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
April 30, 2024 | 97.32% |
April 29, 2024 | 92.46% |
April 26, 2024 | 81.85% |
April 25, 2024 | 80.38% |
April 24, 2024 | 95.71% |
April 23, 2024 | 92.31% |
April 22, 2024 | 87.55% |
April 19, 2024 | 79.89% |
April 18, 2024 | 82.52% |
April 17, 2024 | 88.02% |
April 16, 2024 | 98.56% |
April 15, 2024 | 106.6% |
April 12, 2024 | 120.7% |
April 11, 2024 | 129.9% |
April 10, 2024 | 127.2% |
April 09, 2024 | 143.8% |
April 08, 2024 | 133.7% |
April 05, 2024 | 129.3% |
April 04, 2024 | 123.1% |
April 03, 2024 | 119.8% |
April 02, 2024 | 124.5% |
April 01, 2024 | 139.2% |
March 28, 2024 | 151.9% |
March 27, 2024 | 144.2% |
March 26, 2024 | 133.9% |
Date | Value |
---|---|
March 25, 2024 | 134.6% |
March 22, 2024 | 140.2% |
March 21, 2024 | 127.2% |
March 20, 2024 | 124.2% |
March 19, 2024 | 118.1% |
March 18, 2024 | 126.3% |
March 15, 2024 | 119.4% |
March 14, 2024 | 114.0% |
March 13, 2024 | 114.4% |
March 12, 2024 | 105.0% |
March 11, 2024 | 106.7% |
March 08, 2024 | 92.47% |
March 07, 2024 | 92.20% |
March 06, 2024 | 87.50% |
March 05, 2024 | 89.44% |
March 04, 2024 | 93.48% |
March 01, 2024 | 69.09% |
February 29, 2024 | 78.61% |
February 28, 2024 | 82.56% |
February 27, 2024 | 86.58% |
February 26, 2024 | 90.39% |
February 23, 2024 | 77.52% |
February 22, 2024 | 73.67% |
February 21, 2024 | 96.02% |
February 20, 2024 | 84.62% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-86.02%
Minimum
May 18 2022
461.8%
Maximum
Jun 13 2023
28.47%
Average
-0.21%
Median
Sep 20 2023
1 Year Total Returns (Daily) Benchmarks
Pfizer Inc | -30.67% |
Insmed Inc | 26.72% |
Altimmune Inc | 29.70% |
Regeneron Pharmaceuticals Inc | 11.08% |
Viking Therapeutics Inc | 273.4% |